FDA cleared the SmartRead(TM) Medical Device Identifier (4100) from BridgeSource Medical Corporation on Sep 29, 2026 under DEN260007, a direct 510(k). The device falls under product code SJJ, Cardiac Device Identifier, regulated at 21 CFR 870.3645 as a Class 2 device. The review panel was Cardiovascular.

FDA logged the submission as received on Mar 24, 2026. The decision came 189 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for BridgeSource Medical Corporation in the last 12 months of the tracker.